State-of-the-art risk stratification for indeterminate pulmonary nodules.
Headquartered in Salt Lake City, ProLung strives to bring immediate non-invasive help to patients and physicians in life-threatening disease through developing The ProLung Test™, which utilizes our patented Electro Pulmonary Nodule Scan™ technology. The ProLung Test determines the likelihood that a patient's lung mass is malignant, and it is immediate, non-invasive, and accurate--offering peace of mind to those waiting months or years for cancer to grow more threatening.
Lung Cancer is the deadliest of all cancers. Each year, it kills 1.4 million people worldwide--more than breast, prostate, colon and melanoma cancers combined.
The solution: early detection using The ProLung Test.
Get in touch with us to set up a consultation, or use the contact form at the bottom of this page to inquire whether The ProLung Test can help your patients.
757 East South Temple, Suite 150
Salt Lake City, UT 84102-1230
United States of America
The ProLung Difference
Without the EPN Scan, patients with lung nodules need up to 6 repeated CT Scans over 3.5 years. EPN Scans are immediate. If you need to, you can move forward immediately.
The EPN Scan utilizes non-invasive early diagnostics of lung cancer, that means completed without radiation, needles or surgery. It may be performed as frequently as your doctor directs without the concern of radiation exposure.
In well controlled trials, the EPN Scan demonstrated 90% accuracy in risk stratifying patients with malignant and benign lesions.
The EPN Scan is only available for purchase in the European Economic Area and European Free Trade Association Countries and is for investigational use only in the U.S. None of the following statements have been approved by the FDA.
Use the form below to contact us. You may also email or call us to make an appointment.